The BLINK study found that +2.50 Add centre-distance multifocal contact lenses (MFCLs) slowed myopia progression but the +1.50 Add didn’t. Further analysis indicates that increased peripheral defocus created by the +2.50 Add only accounted for around 15% of the myopia control effect, indicating other mechanisms are involved.
The NaturalVue Multifocal contact lens by Visioneering Technologies, Inc, is a daily disposable contact lens for myopia control. This blog explores the optical profile, proposed mechanism and research evidence for the NaturalVue, along with its application in practice.
When prescribing myopia controlling contact lenses for children, daily disposables are the safest modality. Only spherical corrections are available, though, which can impact lens selection for children with astigmatism. The NaturalVue Multifocal contact lens is suggested for up to 2D of astigmatism, much higher than is typical for spherical CL designs. Is is ‘masking’ astigmatism, or ‘partially correcting’ it instead?
The NaturalVue Multifocal contact lens is a daily disposable which may slow myopia. It is recommended for low astigmatism, as is typical for spherical contact lenses, but its unique optical profile has led practitioners to ask if it can be fit to patients with higher levels of astigmatism. Read this case which highlights the dynamics of a young visual system, using the fitting guide and finding the best solution for a very high myope.
The purpose of this 2 year study was to determine the effect of MiSight contact lenses used to control myopia on binocular vision and accommodation in children, as compared with children wearing SV spectacles, with the researches finding no significant differences in binocular and accommodative measures between the study groups.
In this review we explore the 6-year results for MiSight 1 day recently presented at the 2020 American Academy of Optometry meeting. Based on the abstract, children who were older at initial fitting (11-15 years) progressed similarly over 3 years to matched children who were treated for 6 years, indicating that older children could still gain a treatment effect from MiSight 1 day.
There’s a common clinical belief that orthokeratology doesn’t work as well in lower myopes for myopia control. This is even sometimes included in conference presentations as prescribing advice. Is orthokeratology useful for control of low myopia? Here’s what’s fact and what’s fiction, when considering its efficacy for low vs high myopia, and orthokeratology vs multifocal contact lens myopia control.
Esophoria at near is a risk factor for myopia development and progression. Does it need to be managed in an emmetropic patient without symptoms? Is this patient a pre-myope, and how should this factor into management? Read this interesting clinical case, where colleagues discuss whether to intervene or not, and how to potentially manage both myopia risk and binocular vision.
Here we focus on clinical advice comparing efficacy between available options which have been researched for myopia control. We also discuss best corrected acuity outcomes, and how MFCLs may influence accommodation, with this potentially linking to myopia control efficacy.
Here we provide clinical advice on considering astigmatism and add power choices, over-refraction and final lens power, and safety outcomes in myopia controlling soft contact lenses.
